Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?
Pp.417-425 Peter R. Brink [Abstract] The Physiology, Pathophysiology and Therapeutic Potential of Gap Junctions in Smooth Muscle Pp.427-440 G. Lagaud, K.P. Davies, K. Venkateswarlu and G.J. Christ [Abstract] Mutagenic Approaches to Modifying Gap Junction Phenotype Pp.441-453 S.N. Zucker and B.J. Nicholson [Abstract] Prospects for Rational Development of Pharmacological Gap Junction Channel Blockers Pp.455-464 David C. Spray, Renato Rozental and Miduturu Srinivas [Abstract] Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy Pp.465-482 J.E. Trosko and R.J. Ruch [Abstract] Connexin-GFPs Shed Light on Regulation of Cell-Cell Communication by Gap Junctions Pp.483-499 Vytas K. Verselis and Feliksas F.
Related Questions
- Who is the target audience for the SIFE Capital Markets Program and what is the best way to educate the audience about capital markets?
- In the properties of my GOA WinForms for Flash project, I have seen that I can target Flash 7 or Flash 9. What is the best target?
- Are Gap Junction Channels a Therapeutic Target and if so What Properties are Best Exploited?